Clinicopathological and Epidemiological Findings in Pet Cats Naturally Infected with Feline Immunodeficiency Virus (FIV) in Australia

Feline immunodeficiency virus (FIV) infection in experimentally infected domestic cats produces characteristic clinical manifestations including hematological changes, neurological disease, neoplasia (most notably lymphoma) and lymphopenia-mediated immunodeficiency predisposing cats to a range of secondary infections. Conflicting reports exist, however, with regard to disease associations and survival time in naturally FIV-infected cats. The purpose of this retrospective case–control study was to investigate the effect of natural FIV infection on hematological, blood biochemical and urinalysis parameters and survival time in three cohorts of pet cats in Australia. Cohorts 1 and 2 were recruited from a large veterinary hospital in Melbourne, Victoria (n = 525 and 282), while a third cohort consisted of cats recruited from around Australia as part of a FIV field vaccine efficacy trial (n = 425). FIV-infected cats in cohorts 1, 2 and 3 were found to have 15/37 (41%), 13/39 (33%) and 2/13 (15%) clinicopathological parameters significantly different to FIV-uninfected cats, respectively. Two changes in FIV-infected cats in cohort 1, hypochromia (low hemoglobin) and hyperglobulinemia, were outside the supplied reference intervals and should serve as diagnostic triggers for FIV testing. Kaplan–Meier survival analysis of cats in cohorts 1 and 2 combined did not find any difference between FIV-infected and FIV-uninfected cats, however a confounding factor was a large euthanasia rate within the first 12 months in both groups. Three significant (p < 0.05) spatial clusters of FIV infection were identified in Melbourne. A possible relationship between FIV infection status and socioeconomic disadvantage was discovered, based on three government indices of socioeconomic status (p < 0.001). Until longitudinal field studies are performed in Australia to further investigate the long-term effects of natural FIV infection, Australian veterinarians should consider FIV to be an important infection of pet cats, and recommend measures to prevent FIV infection.

[1]  R. Malik,et al.  Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management , 2022, Australian veterinary journal.

[2]  D. Gunn-Moore,et al.  Age-related cognitive impairments in domestic cats naturally infected with feline immunodeficiency virus. , 2022, The Veterinary record.

[3]  S. Meazzi,et al.  Haematological and biochemical reference intervals in healthy Ragdoll cats , 2022, Journal of feline medicine and surgery.

[4]  K. Freeman,et al.  Evaluation of Sysmex XT-2000iV analyzer performance across a network of five veterinary laboratories using a commercially available quality control material. , 2021, Veterinary clinical pathology.

[5]  J. Suchodolski,et al.  A prospective epidemiological, clinical, and clinicopathologic study of feline leukemia virus and feline immunodeficiency virus infection in 435 cats from Greece. , 2021, Comparative immunology, microbiology and infectious diseases.

[6]  A. D. Munhoz,et al.  Hematological and biochemical aspects of cats naturally infected with feline immunodeficiency virus and feline leukemia , 2020, Brazilian Journal of Veterinary Medicine.

[7]  M. Ward,et al.  Risk of Feline Immunodeficiency Virus (FIV) Infection in Pet Cats in Australia is Higher in Areas of Lower Socioeconomic Status , 2019, Animals : an open access journal from MDPI.

[8]  R. Malik,et al.  Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians. , 2019, Australian veterinary journal.

[9]  D. Proverbio,et al.  Survival time and effect of selected predictor variables on survival in owned pet cats seropositive for feline immunodeficiency and leukemia virus attending a referral clinic in northern Italy. , 2018, Preventive veterinary medicine.

[10]  G. Machado,et al.  Hematological findings and factors associated with feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) positivity in cats from southern Brazil , 2017 .

[11]  I. Lilliehöök,et al.  Feline Differential Leukocyte Count with ProCyte Dx: Frequency and Severity of a Neutrophil‐Lymphocyte Error and How to Avoid It , 2017, Journal of veterinary internal medicine.

[12]  M. Gates,et al.  Epidemiology and clinical outcomes of feline immunodeficiency virus and feline leukaemia virus in client-owned cats in New Zealand , 2017, JFMS open reports.

[13]  L. Hudson,et al.  Feline Immunodeficiency Virus Neuropathogenesis: A Model for HIV-Induced CNS Inflammation and Neurodegeneration , 2017, Veterinary sciences.

[14]  R. Malik,et al.  The protective rate of the feline immunodeficiency virus vaccine: An Australian field study. , 2016, Vaccine.

[15]  M. Ward,et al.  Seroprevalence of feline immunodeficiency virus and feline leukaemia virus in Australia: risk factors for infection and geographical influences (2011–2013) , 2016, JFMS open reports.

[16]  R. Malik,et al.  Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits. , 2015, Comparative immunology, microbiology and infectious diseases.

[17]  M. Krockenberger,et al.  Bias in feline plasma biochemistry results between three in-house analysers and a commercial laboratory analyser: results should not be directly compared , 2015, Journal of feline medicine and surgery.

[18]  D. Bienzle,et al.  Association between oral health status and retrovirus test results in cats. , 2014, Journal of the American Veterinary Medical Association.

[19]  J. Beatty.  Viral causes of feline lymphoma: retroviruses and beyond. , 2014, Veterinary journal.

[20]  T. Ganz,et al.  Anemia of inflammation. , 2014, Hematology/oncology clinics of North America.

[21]  M. Fry,et al.  Analytical performance of a dry chemistry analyzer designed for in-clinic use. , 2014, Veterinary clinical pathology.

[22]  S. Taniwaki,et al.  Virus–host interaction in feline immunodeficiency virus (FIV) infection , 2013, Comparative Immunology, Microbiology and Infectious Diseases.

[23]  J. Beatty,et al.  Clinical findings and survival in cats naturally infected with feline immunodeficiency virus. , 2013, Journal of veterinary internal medicine.

[24]  M. Dunowska,et al.  Sequence variation of the feline immunodeficiency virus genome and its clinical relevance , 2013, Veterinary Record.

[25]  M. Pistello,et al.  Renal Alterations in Feline Immunodeficiency Virus (FIV)-Infected Cats: A Natural Model of Lentivirus-Induced Renal Disease Changes , 2012, Viruses.

[26]  N. Gómez,et al.  Immune-endocrine interactions in treated and untreated cats naturally infected with FIV. , 2011, Veterinary immunology and immunopathology.

[27]  E. Magden,et al.  FIV associated neoplasms--a mini-review. , 2011, Veterinary immunology and immunopathology.

[28]  A. Oxenius,et al.  Antigen-Dependent and -Independent Mechanisms of T and B Cell Hyperactivation during Chronic HIV-1 Infection , 2011, Journal of Virology.

[29]  Allen G Rodrigo,et al.  Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus). , 2010, Veterinary immunology and immunopathology.

[30]  R. Malik,et al.  Association between naturally occurring chronic kidney disease and feline immunodeficiency virus infection status in cats. , 2010, Journal of the American Veterinary Medical Association.

[31]  E. Thiry,et al.  Feline Immunodeficiency: ABCD Guidelines on Prevention and Management , 2009, Journal of Feline Medicine & Surgery.

[32]  H. Tsujimoto,et al.  Prevalence of hematological abnormalities and detection of infected bone marrow cells in asymptomatic cats with feline immunodeficiency virus infection. , 2009, Veterinary microbiology.

[33]  K. Hartmann,et al.  Hematology and serum biochemistry of feline immunodeficiency virus-infected and feline leukemia virus-infected cats. , 2009, Journal of veterinary internal medicine.

[34]  S. Holloway,et al.  Molecular subtyping of feline immunodeficiency virus from cats in Melbourne. , 2008, Australian veterinary journal.

[35]  S. Lecollinet,et al.  Vaccination against the feline immunodeficiency virus: the road not taken. , 2008, Comparative immunology, microbiology and infectious diseases.

[36]  H. Lefebvre,et al.  Comparison of plasma creatinine values measured by different veterinary practices , 2008, Veterinary Record.

[37]  T. Brown,et al.  Thyroid function abnormalities in HIV-infected patients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  S. Paltrinieri.  The feline acute phase reaction , 2007, The Veterinary Journal.

[39]  J. Toribio,et al.  Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia , 2007, Journal of feline medicine and surgery.

[40]  E. Sato,et al.  Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine. , 2007, AIDS.

[41]  A. Rodrigo,et al.  Phylogenetic Analysis of Feline Immunodeficiency Virus in Feral and Companion Domestic Cats of New Zealand , 2006, Journal of Virology.

[42]  A. Duarte,et al.  Phylogenetic analysis of Portuguese Feline Immunodeficiency Virus sequences reveals high genetic diversity. , 2006, Veterinary microbiology.

[43]  J. Meers,et al.  Molecular subtyping of feline immunodeficiency virus from domestic cats in Australia. , 2006, Australian veterinary journal.

[44]  J. Levy,et al.  Effects of passive transfer of immunity on results of diagnostic tests for antibodies against feline immunodeficiency virus in kittens born to vaccinated queens. , 2004, Journal of the American Veterinary Medical Association.

[45]  E. Uhl,et al.  FIV vaccine development and its importance to veterinary and human medicine: a review , 2002, Veterinary Immunology and Immunopathology.

[46]  R. Malik,et al.  Feline immunodeficiency virus status of Australian cats with lymphosarcoma. , 2001, Australian veterinary journal.

[47]  R. Malik,et al.  Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in cats in Sydney. , 1997, Australian veterinary journal.

[48]  R. Hofmann-Lehmann,et al.  Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets , 1997, Clinical and diagnostic laboratory immunology.

[49]  G. Hoffmann-Fezer,et al.  Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus. , 1996, Research in veterinary science.

[50]  C. Lawrence,et al.  Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study. , 1995, Immunology.

[51]  R. Hofmann-Lehmann,et al.  FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets. , 1995, Veterinary immunology and immunopathology.

[52]  J. Abkowitz,et al.  Prospective Hematologic and Clinicopathologic Study of Asymptomatic Cats With Naturally Acquired Feline Immunodeficiency Virus Infection , 1995, Journal of veterinary internal medicine.

[53]  D. Love,et al.  Analysis of leucocytes and lymphocyte subsets for different clinical stages of naturally acquired feline immunodeficiency virus infection. , 1994, Veterinary immunology and immunopathology.

[54]  I. Robertson,et al.  Leukogram and biochemical abnormalities in naturally occurring feline immunodeficiency virus infection , 1993 .

[55]  C. Lawrence,et al.  Clinical and pathological findings in feline immunodeficiency virus experimental infection , 1992, Veterinary Immunology and Immunopathology.

[56]  N. Pedersen,et al.  Detection of feline immunodeficiency virus infection in bone marrow of cats. , 1992, Veterinary immunology and immunopathology.

[57]  G. Hoffmann-Fezer,et al.  Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection , 1992, Journal of virology.

[58]  N. Pedersen,et al.  Long-term haematological changes in cats experimentally infected with feline immunodeficiency virus (FIV) , 1992, Comparative Haematology International.

[59]  N. Pedersen,et al.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus , 1991, Journal of virology.

[60]  I. Abramson,et al.  The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.

[61]  N. Pedersen,et al.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus , 1990, Journal of virology.

[62]  M. Peterson,et al.  Effect of nonthyroidal illness on serum thyroxine concentrations in cats: 494 cases (1988). , 1990, Journal of the American Veterinary Medical Association.

[63]  C. Birch,et al.  Feline immunodeficiency virus: prevalence, disease associations and isolation. , 1990, Australian veterinary journal.

[64]  N. Pedersen,et al.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. , 1987, Science.

[65]  Edgar B. Smith,et al.  An Update and Review , 2016 .

[66]  C. K. Grant,et al.  Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. , 2010, Current HIV research.

[67]  J. Beatty,et al.  Vaccine protection against feline immunodeficiency virus: setting the challenge. , 2007, Australian veterinary journal.

[68]  I. Robertson,et al.  Association of renal disease indicators with feline immunodeficiency virus infection , 1993 .

[69]  R. Sutherland,et al.  Feline immunodeficiency virus and feline leukaemia virus in cats. , 1990 .